While GLP-1 physiology informs the development of therapeutic agents, the native peptide itself cannot be practically administered for disease management
Customized guidance simplifies managing obstacles, monitoring outcomes, and shifting directions when necessary
Orforglipron, made by the same company that produces the GLP-1 medications Zepbound and Mounjaro (tirzepatide), is an oral medication undergoing FDA clinical tests for use in weight loss
It treats the symptoms high blood sugar, excess weight as if the problem is simply behavior or willpower , rather than a dysregulated metabolic system defending a higher set point
Because appetite and thirst signals may both decrease, many users unintentionally fall behind on fluid intake throughout the day without noticing immediately
GIP also plays important roles in fat metabolism